Q1 2026 Medivir AB Earnings Call Transcript
Welcome to Medivir Q1 Report 2026.(Operator Instructions). Now I will hand the conference over to CEO Jens Lindberg. Please go ahead.
Thank you, operator. Welcome, everyone, to the Medivir Q1 2026 results webcast. We look back at a transformative quarter where we've strengthened our financial position. We've opened up a new rare disease opportunity with MIB 7/11, and we just came back from a successful and quite invigorating trip to Korea, where we visited a number of the highly engaged hospitals and investigators now sort of eager to get going in the FLEX-HCC study. Pia will share more on that particular topic in just a little bit. We've also seen our partner, Vetbiolix in France make great progress in the past quarter. So, we are looking ahead to the remainder of 2026 with great anticipation.
As mentioned, so that we are, so we've just come back from Korea, and the interest in the FLEX-HCC study is very strong among the hospitals. And the interest to participate in the study is quite high. So, the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
